State innovation waiver under section 1332 of the affordable care act

The Centers for Medicare and Medicaid Services awarded Nevada Health Authority $28.914 million on January 1, 2026, under the 1332 State Innovation Waivers program (CFDA 93.423), a five-year block grant running through December 31, 2030. Under Section 1332 of the Affordable Care Act, Nevada's approved waiver permits the state to pursue innovative strategies adapted to its specific healthcare needs while maintaining coverage at least as comprehensive, affordable, and broad as coverage without the waiver and without increasing the federal deficit. The award funds pass-through dollars resulting from federal spending reductions on Exchange financial assistance, which Nevada may deploy to implement its approved waiver plan. Unused pass-through funding rolls over annually for continued waiver implementation; if the waiver is not extended, amended, suspended, or terminated, remaining funds return to the Treasury. Assistance is released quarterly via the Payment Management System. Performance occurs statewide in Nevada.